Explore Watchlists Pricing

CATALYST PHARMACEUTICALS, INC. (CPRX) Balance sheet

Market cap

$3.8B

P/E ratio

18.6x

Summary Financials

Income statement Balance sheet Cash flow Other

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	6	1	2	9	28	14	57	17	90	130	171	298	138	518	709
Total cash & short-term investments	6	1	2	9	28	14	57	17	90	130	171	298	138	518	709
Accounts receivable, net	-	-	-	-	-	-	-	-	11	6	7	10	54	65	126
Inventories	-	-	-	-	-	-	-	56,012	2	5	8	7	16	20	37
Total current assets	6	17	25	44	60	41	85	55	111	159	210	321	219	624	894
Property, plant and equipment, net	12,186	53,679	40,628	71,377	191,549	244,204	191,385	245,425	210,467	129,800	1	1	1	1	1
Marketable securities, non-current	-	-	-	-	-	-	-	5	-	-	-	-	-	-	-
Total assets	6	17	25	44	60	42	85	60	112	192	238	376	470	851	1,104
Accounts payable	263,934	1	850,789	2	2	933,176	2	2	4	4	3	4	15	17	11
Total current liabilities	833,801	2	2	6	3	2	4	10	24	23	27	58	76	121	147
Total liabilities	2	2	4	9	5	2	4	10	25	23	31	75	82	124	150
Retained earnings	-38,102,617	-42,179,003	-54,333,599	-69,842,660	-90,075,618	-108,148,070	-126,560,447	-160,563,961	-128,688,624	-53,705,624	-26	50	121	285	474
Stockholders' equity	4	15	21	35	55	39	81	51	88	170	207	300	388	728	954
Working capital	-	-	-	-	-	-	-	-